A NATION’S PRIORITIES
If you were a casual
viewer of the news this week, you sure heard a lot about Carnival Cruise’s Voyage
to Hell and Back. And you probably didn’t
miss the story about how an “inspirational hero” from the last Olympics – the so-called
“blade runner” – is now accused of murder in South Africa. But while these human-interest stories
gathered all the attention, other more important stories slid through the
cracks. These include the coverage of a brief
statement that President Obama made in Tuesday’s State of the Union Address to
address the high cost of prescription drugs to the Medicare program.
Let
me first of all remind everyone that the State of the Union Address is a speech
given annually by the President of the United States to explain his plans for
the upcoming year. Ten years ago, it was
watched by 63 million Americans. This
Tuesday night’s speech was viewed by a mere 33 million – and most of those
probably had turned on their TV to watch Cougar Town but were too tired to
change the channel. The President’s
address contained a number of suggestions about how the nation can upgrade its
infrastructure, better educate its youth, clean up its environment, and address
its ballooning debt. And with respect to
that last goal, the President proposed to “reduce taxpayer subsidies to
prescription drug companies.” Sounds
reasonable enough, right? You’d think –
but then again, according to the New York Times, the President faces an “uphill
road” if he hopes to tackle those subsidies in earnest.
According to published
reports, what the President had in mind would change the way the Government
pays for the costs of drugs provided to the ten-million beneficiaries who are
eligible for both Medicare and Medicaid.
Under existing law, these dual-eligible patients are covered by Medicare,
which means that the federal government has been compensating the drug
companies based on the Medicare rate. That
rate, however, is more generous to the drug companies than the Medicaid rate. The change in the law that the President
would like to see would enable the Government to receive the same discounts for
covering the dual-eligible patients that it would have received if the patients
were solely eligible for Medicaid.
Such a change may not
sound like a big deal, but the numbers tell a different story. While estimates of the proposed savings vary
depending on who you believe, everyone agrees that the American taxpayers would
save more than $100 billion dollars over the next decade – and perhaps as much
as $150 billion. Everyone also seems to
agree that the current approach is, in essence, a subsidy to the pharmaceutical
industry. Where people divide is on the
issue of whether such a subsidy is appropriate. Some say that it is crucial to ensure that drug
companies have the money to continue to make as many advances as possible in
medical research. Others say that subsidizing
an industry with $300 billion in annual revenues is not something that a
society mired in many trillions of dollars in debt can afford.
I’ll spare you my own
thoughts on the wisdom of those subsidies.
You can probably figure them out without much trouble if you read this blog
on a regular basis. But what matters is
not what I think as an individual, but what we think as a society – and how
little that seems to matter to the policies that are ultimately adopted by our
Government. You see, the Administration
suggested this same change last year in its proposed budget, the suggestion was
opposed by the pharmaceutical industry, it was never implemented, and the mass
media gave virtually no attention to the issue – just like it gives virtually
no attention to the other corporate subsidies that we as taxpayers provide
every year.
Are
we willingly providing 12-digit subsidies to well-heeled industries? And if not, why do our “representatives”
provide them and our “journalists” ignore them?
Say what you want about the wisdom of our various corporate subsidies,
but you’d have to at least agree that they are newsworthy.
And
now back to your regularly scheduled story about flowing urine on the high
seas.
No comments:
Post a Comment